SEC Form 4 · accession 0001209191-17-039002
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jorma Routti
Director
Period of report
Jun 7, 2017
Accepted (ET)
Jun 9, 2017 · 6:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $28.65 | Jun 7, 2017 | A | 12,000 | A | — | Jun 7, 2027 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1The shares subject to the option vest and become exercisable quarterly over one year measured from June 7, 2017.